Skip to Main Content

INFORMATION FOR

Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

Prospective, multi-center, double-blind, randomized pivotal trial to evaluate the safety and effectiveness of the DrugSorb-ATR system for intraoperative removal of ticagrelor in patients undergoing urgent cardiothoracic (CT) surgery with cardiopulmonary bypass (CPB).

  • Trial with
    CytoSorbents, Inc.
  • Start Date
    06/21/2022
  • End Date
    12/31/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #2000031980